B2DB — Who said what, where, and when

Brit Mollenhauer

Paracelsus-Elena-Klinik Kassel

Brit Mollenhauer is listed as Paracelsus-Elena-Klinik Kassel. Brit spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (speaker, “DGN-PWP-38 Parkinson verhindern statt Symptome behandeln: Früherkennung und Prävention im Fokus”). Brit is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 19 March 2027.

Compiled from published conference agendas; not yet confirmed by Brit. Is this you? Claim this profile.

About

Brit Mollenhauer, MD, received her medical degree from the University Medical Center in Goettingen, Germany, in 2000 followed by the residency training in neurology until 2005. From 2005 to 2007, Dr. Mollenhauer visited Harvard Medical School in Boston,USA, as a postdoctoral fellow in the lab of Michael Schlossmacher. There she worked on developing biomarkers and studied alpha-synuclein and other proteins in cerebrospinal fluid. In 2007 she became assistant professor of Neurology at University Medical Center Goettingen (UMG) and attending at Movement Disorder Paracelsus-Elena-Klinik, Kassel (PEKK, former chief physician Claudia Trenkwalder). She is now chief physician at PEKK and Associate Professor at UMG. Given Dr. Mollenhauer's background in neurochemistry, her research team focuses on the detection of biomarkers in human body fluids (nowadays mainly in peripheral blood or skin biopsies) and the development of experimental techniques for improved and early diagnosis of movement diso

Upcoming

AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027

Sessions at 1 conference

DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) 4 November 2026 – 7 November 2026